Martin Mayora Neto

The paper uses pseudotyped viruses and structural analysis to identify shared antigenic sites between influenza C and D viruses, suggesting potential for cross-protective vaccines.

This study identifies HAT and swAT as proteases that activate ICV and IDV HEF proteins, showing that protease specificity does not restrict IDV replication in the human upper respiratory tract.

This paper introduces a dual neutralisation assay for SARS-CoV-2 and influenza viruses, demonstrating its sensitivity and specificity in detecting neutralising antibodies.

The paper develops and optimizes pseudotyped viruses for influenza C and D to enable antiviral screening and sero-epidemiological studies.

The paper identifies monoclonal antibodies that neutralize multiple SARS-CoV-1, SARS-CoV-2 variants, and bat coronaviruses, with one antibody showing broad cross-reactivity.

The paper analyzes neutralizing antibodies from vaccinated and hybrid immune individuals to show that restored B cell germlines enhance neutralization against SARS-CoV-2 variants like BA.2.86.